SK

Group14 Technologies Commences Phase I Expansion into Europe with the Planned Restart of its Silane Manufacturing Factory in Germany

Retrieved on: 
목요일, 11월 9, 2023
EV, Original equipment manufacturer, Acquisition, Engineering, BASF, Economic development, Electronics, Porsche, Silicon, SK, Renewable energy

WOODINVILLE, Wash. and SPREETAL, Germany, Nov. 9, 2023 /PRNewswire/ -- Group14 Technologies, the leading global manufacturer and supplier of advanced silicon battery technology, announced the commencement of Phase I of its European manufacturing roadmap by beginning preparations to restart operations at its newly-acquired silane factory in Spreetal, Germany. Idled since 2016, the silane factory will manufacture a necessary precursor for many energy storage applications including silicon batteries and solar panels.

Key Points: 
  • Idled since 2016, the silane factory will manufacture a necessary precursor for many energy storage applications including silicon batteries and solar panels.
  • Long recognized as the manufacturing powerhouse of Europe, Germany is expected to surpass Japan to become the third-largest economy in the world this year.
  • A prime location for Group14 to establish its foothold in Europe, Germany is home to many global brands including the company's partners and investors such as Porsche AG and BASF.
  • As part of Phase I of its European expansion plans, Group14 will leverage its advanced technology and manufacturing expertise to restart the idled silane factory in Spreetal, Germany.

Africa CDC Director General Visits SK bioscience to Discuss Vaccine Localization in Africa

Retrieved on: 
일요일, 11월 5, 2023
African, Health, Therapy, Public health, Vaccine, GPO, HIV, Malaria, Disease, AU, Research, R, Republic, Government Pharmaceutical Organization, MOU, CDC, Partnership, Korea Carbon Capture & Sequestration R&D Center, Infection, African Union, Pandemic, Hepatitis B, SK, African Center for Economic Transformation, Tuberculosis, Africa Centres for Disease Control and Prevention, Pharmaceutical industry

H.E Dr. Jean Kaseya, Director General of the African Centers for Disease Control and Prevention (Africa CDC), visited SK bioscience to discuss the vaccine localization program in the African continent.

Key Points: 
  • H.E Dr. Jean Kaseya, Director General of the African Centers for Disease Control and Prevention (Africa CDC), visited SK bioscience to discuss the vaccine localization program in the African continent.
  • SK bioscience introduced the 'Glocalization Project' which is transplanting R&D and manufacturing capabilities to countries that lack sufficient vaccine infrastructures.
  • SEONGNAM, South Korea, Nov. 5, 2023 /PRNewswire/ -- SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that H.E Dr. Jean Kaseya, Director General of Africa CDC visited SK bioscience headquarters on November 3 to discuss collaboration with the Partnerships for African Vaccine Manufacturing (PAVM).
  • Dr. Kaseya was appointed as the Director General of Africa CDC in February 2023.

Amcor, SK Geo Centric partner for supply of recycled content

Retrieved on: 
목요일, 10월 26, 2023
ASX, Pyrolysis, MOU, AMC, Food, SK, NYSE, ExxonMobil, AMCR, Recycling, Amcor

Combined, these partnerships will help Amcor take another important step toward achieving its target of 30% recycled content across its portfolio by 2030.

Key Points: 
  • Combined, these partnerships will help Amcor take another important step toward achieving its target of 30% recycled content across its portfolio by 2030.
  • "Our ability to deliver more sustainable packaging solutions containing recycled material is increasingly important to customers in all consumer categories," said Mike Cash, president of Amcor Flexibles Asia Pacific.
  • SK Geo Centric CEO Na Kyung-soo said, "We are committed to contributing to a circular economy by expanding the supply chain where pyrolysis oil, produced from end-of-life plastic, can provide recycled content in consumer packaging.
  • SK extracts pyrolysis oil from end-of-life plastic waste that would otherwise be sent to landfill.

Amcor, SK Geo Centric partner for supply of recycled content

Retrieved on: 
목요일, 10월 26, 2023
ASX, Pyrolysis, MOU, AMC, Food, SK, NYSE, ExxonMobil, AMCR, Recycling, Amcor

Combined, these partnerships will help Amcor take another important step toward achieving its target of 30% recycled content across its portfolio by 2030.

Key Points: 
  • Combined, these partnerships will help Amcor take another important step toward achieving its target of 30% recycled content across its portfolio by 2030.
  • "Our ability to deliver more sustainable packaging solutions containing recycled material is increasingly important to customers in all consumer categories," said Mike Cash, president of Amcor Flexibles Asia Pacific.
  • SK Geo Centric CEO Na Kyung-soo said, "We are committed to contributing to a circular economy by expanding the supply chain where pyrolysis oil, produced from end-of-life plastic, can provide recycled content in consumer packaging.
  • SK extracts pyrolysis oil from end-of-life plastic waste that would otherwise be sent to landfill.

Centinel Spine® PMA Application for First-of-its-Kind 2-Level prodisc® C Vivo and prodisc C SK Match-the-Disc™ Cervical Total Disc Replacement System Filed and Proceeding with Substantive Review

Retrieved on: 
목요일, 10월 26, 2023
Anatomy, FDA, Arthroplasty, Investigational device exemption, Food, TDR, Health, PMA, WEST, IDE, Clinical trial, Surgeon, Samuel Bryan, Safety, SK, Food and Drug Administration Amendments Act of 2007, Pharmaceutical industry, Medical device

The clinical trial evaluated the safety and effectiveness of the prodisc C Vivo and prodisc C SK system by comparing it with an approved total disc replacement (TDR) product as a control for 2-level indications.

Key Points: 
  • The clinical trial evaluated the safety and effectiveness of the prodisc C Vivo and prodisc C SK system by comparing it with an approved total disc replacement (TDR) product as a control for 2-level indications.
  • The filing date for the Company's PMA application was September 27, 2023 and the submission is now under substantive review by the FDA.
  • "The prodisc C Vivo and prodisc C SK 2-level cervical disc clinical trial was unique in two ways," said Centinel Spine CEO Steve Murray.
  • The prodisc C Vivo system has been in clinical use internationally since 2009 and is currently one of the most frequently implanted TDR devices in the world.

External Hard Disk Market to increase by USD 3.24 billion between 2022 to 2027, ADATA Technology Co. Ltd., Apple Inc., Buffalo Americas Inc., and more among key companies - Technavio

Retrieved on: 
목요일, 10월 26, 2023
Apple Inc., HP, Asus, Intel, Personal, HDD, Acer Inc., TB, Enterprise, Growth, Western Digital, Electronics, USD, Quantum Corporation, SK, Micron Technology, Dell Technologies, Computer data storage, Video game, Geography, Lenovo

NEW YORK, Oct. 25, 2023 /PRNewswire/ -- The external hard disk market size is expected to grow by USD 3.24 billion from 2022 to 2027.

Key Points: 
  • NEW YORK, Oct. 25, 2023 /PRNewswire/ -- The external hard disk market size is expected to grow by USD 3.24 billion from 2022 to 2027.
  • Multiple advantages of external hard disks are notably driving the external hard disk market.
  • External Hard Disk Market 2023-2027: Company Analysis
    ADATA Technology Co. Ltd. - The company offers an external hard disk that comes with up to 4TB of additional storage, where one can play wherever one wants.
  • Buy Now for detailed company information
    External Hard Disk Market 2023-2027: Segmentation
    By application, the market is segmented into personal computers and enterprise applications.

SK hynix Reports Third Quarter 2023 Financial Results

Retrieved on: 
목요일, 10월 26, 2023
LPDDR5, HBM, Growth, NAND, DRAM, AI, SK, TSV, Investment, Silicon, DDR5, Lead, HBM3, Through-silicon via, Video game, Computer data storage

SEOUL, South Korea, Oct. 25, 2023 /PRNewswire/ -- SK hynix Inc. (or "the company", www.skhynix.com) today reported the financial results for the third quarter ended September 30, 2023. The company recorded revenues of 9.066 trillion won, operating losses of 1.792 trillion won and net losses of 2.185 trillion won in the three-month period. The operating and net margins were a negative 20% and 24%, respectively.

Key Points: 
  • - Technical prowess, competitive products help expand revenues, narrow operating losses
    - DRAM turns around from two quarters of losses, helped by brisk sales of premium products
    SEOUL, South Korea, Oct. 25, 2023 /PRNewswire/ -- SK hynix Inc. (or "the company", www.skhynix.com ) today reported the financial results for the third quarter ended September 30, 2023.
  • SK hynix attributed the growth in sales to increased shipments of both DRAM and NAND and a rise in the average selling price.
  • To meet new demands, SK hynix plans to increase investments in high-value flagship products such as HBM, DDR5, and LPDDR5.
  • Kim Woohyun, the chief financial officer at SK hynix, said that the company has been consolidating its position as the key player in the future AI infrastructure with its leadership in the high-performance memory market.

DermBiont Announces First Close of $35.2 Million in a Series B Financing to Advance First-in-Class Targeted Topical Dermatological Therapeutics

Retrieved on: 
화요일, 10월 24, 2023
Biotechnology, Pharmaceutical, Health, Clinical Trials, Olive, FDA, Viking Global Investors, Food, Hyperpigmentation, Therapy, PKC, Skin, DPN, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Laser, Melasma, Physician, Recurrence, Venture round, Civilization, Dermatology, Safety, SKS, SK, Series, Patient, AKT, Dermatosis papulosa nigra, Pharmaceutical industry, Dietary supplement

DermBiont, a clinical-stage biotechnology company that is advancing targeted topical therapeutics for the treatment of dermatological indications, today announced a $35.2 million Series B financing, including a $27.1 million Series B first close and $8.1 million in converting outstanding notes.

Key Points: 
  • DermBiont, a clinical-stage biotechnology company that is advancing targeted topical therapeutics for the treatment of dermatological indications, today announced a $35.2 million Series B financing, including a $27.1 million Series B first close and $8.1 million in converting outstanding notes.
  • The Series B was led by new institutional investor, Double Point Ventures, and includes continued support from Viking Global Investors, Civilization Ventures, Olive Tree Capital, and others.
  • These products prioritize the patient experience by addressing the root cause of both diseases with excellent efficacy, safety, and tolerability.
  • Phase 2b open label clinical trial in 10 subjects with DPN (Dermatosis Papulosa Nigra) treated with SM-020 gel 1% twice daily for 28 days.

Latest news - Next CULT Committee meetings on 27-28 November - Committee on Culture and Education

Retrieved on: 
목요일, 10월 26, 2023
PDF, Parliament, Newsletter, Research, Budget, SL, News, EP, SV, COVID-19, GA, SK, European, Publication, Adobe Creative Cloud, Rural development, European Parliament, Justice, FI, Food safety, MT, Employment, PT, HU, Democrat, Cancer, Home, LV, RO, Committee, EL, Culture, Contract, Member of the European Parliament, EN, Education, Tourism, DA, Public health, Danish, DE, PL, CS, Artificial intelligence, LT, FR, Open data portal, BG, Customer service, Online shopping, Furniture, Typesetting, Airline, Oil, Cosmetics, Consumer electronics, Construction, Whaling, Car rental, Publishing, Employment agency, Plaster, Dairy, Tax advisor, Livestock, Vaccine, Information technology, Residential care, Fair, Pegasus, Animal

Access to page content (press "Enter")

Key Points: 
  • Access to page content (press "Enter")
    Direct access to language menu (press "Enter")
    Direct access to search menu (press "Enter")
    EN - English
    BG - български
    ES - español
    CS - čeština
    DA - dansk
    DE - Deutsch
    ET - eesti keel
    EL - Ελληνικά
    EN - English
    FR - français
    GA - Gaeilge
    HR - hrvatski
    IT - italiano
    LV - latviešu valoda
    LT - lietuvių kalba
    HU - magyar
    MT - Malti
    NL - Nederlands
    PL - polski
    PT - português
    RO - română
    SK - slovenčina
    SL - slovenščina
    FI - suomi
    SV - svenska
    News
    MEPs
    About Parliament
    Plenary
    Committees
    Delegations
    Other websites
    Other websites
    News
    MEPs
    About Parliament
    Plenary
    Committees
    Delegations
    Multimedia Centre
    President’s website
    Secretariat-general
    Think tank
    EP Newshub
    At your service
    Visits
    Legislative train
    Contracts and Grants
    Register
    Open Data Portal
    Liaison offices
    Committees
    European Parliament
    Search
    Search
    Please fill this field
    CULT
    European Parliament
    Search
    Menu
    Choose your committee
    Choose your committee
    All committees - Homepage
    Foreign Affairs
    Human Rights
    Security and Defence
    Development
    International Trade
    Budgets
    Budgetary Control
    Economic and Monetary Affairs
    Tax Matters
    Employment and Social Affairs
    Environment, Public Health and Food Safety
    Public Health
    Industry, Research and Energy
    Internal Market and Consumer Protection
    Transport and Tourism
    Regional Development
    Agriculture and Rural Development
    Fisheries
    Culture and Education
    Legal Affairs
    Civil Liberties, Justice and Home Affairs
    Constitutional Affairs
    Women’s Rights and Gender Equality
    Petitions
    Beating Cancer
    COVID-19 pandemic: lessons learned and recommendations for the future
    Special Committee on foreign interference and disinformation, and on strengthening integrity in the EP
    Foreign Interference in all Democratic Processes in the European Union, including Disinformation
    Artificial Intelligence in a Digital Age
    Protection of Animals during Transport
    Use of Pegasus and equivalent surveillance spyware
    Go to the page
    CULT
    Home
    Highlights
    Members
    Press releases
    Newsletters
    Publications
    Subject files
    Meetings
    Meeting documents
    Webstreaming
    Votes
    Minutes
    Documents
    Latest documents
    Search
    Work in progress
    Events
    Hearings
    Workshops
    Meetings with National Parliaments
    European Citizens’ Initiatives
    Supporting analyses
    Latest documents
    Search
    Presentation
    About
    Go back
    CULT
    Home
    Highlights
    Next CULT Committee meetings on 27-28 November
    Next CULT Committee meetings on 27-28 November
    25-10-2023 - 09:47
    Share this page on Facebook
    Share this page on Twitter
    Share this page on LinkedIn
    Autumn © Image used under the license of Adobe Stock
    Provisional calendar of CULT Committee meetings for 2023
    (PDF - 218 KB)
    Provisional calendar of CULT Committee meetings for the first half of 2024
    (PDF - 215 KB)
    List of CULT Coordinators - as of February 2023
    (PDF - 117 KB)
    EP calendar 2023
    (PDF - 580 KB)

SK hynix's LPDDR5T, World's Fastest Mobile DRAM, Completes Compatibility Validation with Qualcomm

Retrieved on: 
수요일, 10월 25, 2023
Processor, DRAM, Smartphone, Victoria's Voice Foundation 200, Product management, Joint Electronics Type Designation System, LLM Communications, Application, Senior, Tablet, Metal gate, Qualcomm, JEDEC, AP, AI, SK, HKMG, Antirrhinum, Video game, Mobile phone, Printed circuit board

*LPDDR: Low power DRAM for mobile devices, including smartphones and tablets, aimed at minimizing power consumption and that features low voltage operation.

Key Points: 
  • *LPDDR: Low power DRAM for mobile devices, including smartphones and tablets, aimed at minimizing power consumption and that features low voltage operation.
  • SK hynix has proceeded with the compatibility validation of the LPDDR5T, following the completion of the development in January, with support from Qualcomm Technologies.
  • SK hynix was the industry's first to integrate the process in mobile DRAM in November.
  • We will continue to work toward strengthening our collaboration with Qualcomm Technologies to advance the technology in this space."